Selected article for: "macrolide unresponsive MP pneumonia and MP pneumonia"
Author: Ha, Seok Gyun; Oh, Kyung Jin; Ko, Kwang-Pil; Sun, Yong Han; Ryoo, Eell; Tchah, Hann; Jeon, In Sang; Kim, Hyo Jeong; Ahn, Jung Min; Cho, Hye-Kyung
Title: Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children
  • Document date: 2018_9_18
    • ID: yrbo0hdk_35
    Snippet: In this study, the macrolide resistance of MP determined by molecular analysis or susceptibility test was not identified. But, this study was based on an actual treatment course for MP pneumonia in a clinical setting. If fever persists despite the use of macrolide, it is necessary to consider a secondary treatment without the results of antimicrobial susceptibility. We compared the therapeutic efficacy of the secondary treatments on clinically as.....
    Document: In this study, the macrolide resistance of MP determined by molecular analysis or susceptibility test was not identified. But, this study was based on an actual treatment course for MP pneumonia in a clinical setting. If fever persists despite the use of macrolide, it is necessary to consider a secondary treatment without the results of antimicrobial susceptibility. We compared the therapeutic efficacy of the secondary treatments on clinically assessed macrolide-unresponsive MP pneumonia.

    Search related documents:
    Co phrase search for related documents
    • macrolide unresponsive and MP pneumonia: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • macrolide unresponsive and secondary treatment: 1, 2, 3, 4, 5
    • macrolide unresponsive and therapeutic efficacy: 1, 2, 3
    • macrolide unresponsive MP pneumonia and MP macrolide resistance: 1, 2
    • macrolide unresponsive MP pneumonia and MP pneumonia: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • macrolide unresponsive MP pneumonia and secondary treatment: 1, 2, 3, 4, 5
    • macrolide unresponsive MP pneumonia and therapeutic efficacy: 1, 2, 3
    • molecular analysis and MP pneumonia: 1
    • molecular analysis and susceptibility test: 1, 2
    • molecular analysis and therapeutic efficacy: 1, 2, 3, 4, 5
    • molecular analysis and treatment course: 1
    • MP macrolide resistance and MP pneumonia: 1, 2, 3, 4
    • MP macrolide resistance and secondary treatment: 1, 2
    • MP macrolide resistance and therapeutic efficacy: 1
    • MP pneumonia and secondary treatment: 1, 2, 3, 4, 5, 6, 7, 8
    • MP pneumonia and therapeutic efficacy: 1, 2, 3
    • secondary treatment and therapeutic efficacy: 1, 2, 3, 4, 5
    • secondary treatment and treatment course: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • therapeutic efficacy and treatment course: 1